Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Estes

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of the American College of Surgeons|August 30, 2008
Conservative management of postoperative Fever in gynecologic patients undergoing major abdominal or vaginal operationsJames E Kendrick, T Michael Numnum, Jacob M Estes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 8, 2015
Does a standardized preoperative algorithm of clinical data improve outcomes in patients with ovarian cancer? A quality improvement projectMonjri M Shah, Charles A Leath, Laura Rebecca Daily, et al.
Journal of the American College of Surgeons|September 27, 2006
Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapyJacob M Estes, Charles A Leath, J Michael Straughn, et al.
Gynecologic Oncology|December 17, 2003
Complications of indwelling venous access devices in patients with gynecologic malignanciesJacob M Estes, Rodney Rocconi, J Michael Straughn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2012
Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?Rodney P Rocconi, Paula Sullivan, Beverly Long, et al.
Gynecologic Oncology|July 12, 2011
Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignanciesAkila Subramaniam, Kenneth H Kim, Shannon A Bryant, et al.
Gynecologic Oncology|February 21, 2006
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancerJacob M Estes, Charles A Leath, Sybilann Williams, et al.
Gynecologic Oncology|September 24, 2004
The impact of aborted radical hysterectomy in patients with cervical carcinomaCharles A Leath, J Michael Straughn, Jacob M Estes, et al.
Gynecologic Oncology|March 1, 2018
Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment ClinicDavid A Barrington, Macie L Champion, Teresa K L Boitano, et al.
Gynecologic Oncology|August 12, 2008
A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinomaKristopher J Kimball, T Michael Numnum, Tyler O Kirby, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of the American College of Surgeons|August 30, 2008
Conservative management of postoperative Fever in gynecologic patients undergoing major abdominal or vaginal operationsJames E Kendrick, T Michael Numnum, Jacob M Estes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 8, 2015
Does a standardized preoperative algorithm of clinical data improve outcomes in patients with ovarian cancer? A quality improvement projectMonjri M Shah, Charles A Leath, Laura Rebecca Daily, et al.
Journal of the American College of Surgeons|September 27, 2006
Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapyJacob M Estes, Charles A Leath, J Michael Straughn, et al.
Gynecologic Oncology|December 17, 2003
Complications of indwelling venous access devices in patients with gynecologic malignanciesJacob M Estes, Rodney Rocconi, J Michael Straughn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2012
Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?Rodney P Rocconi, Paula Sullivan, Beverly Long, et al.
Gynecologic Oncology|July 12, 2011
Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignanciesAkila Subramaniam, Kenneth H Kim, Shannon A Bryant, et al.
Gynecologic Oncology|February 21, 2006
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancerJacob M Estes, Charles A Leath, Sybilann Williams, et al.
Gynecologic Oncology|September 24, 2004
The impact of aborted radical hysterectomy in patients with cervical carcinomaCharles A Leath, J Michael Straughn, Jacob M Estes, et al.
Gynecologic Oncology|March 1, 2018
Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment ClinicDavid A Barrington, Macie L Champion, Teresa K L Boitano, et al.
Gynecologic Oncology|August 12, 2008
A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinomaKristopher J Kimball, T Michael Numnum, Tyler O Kirby, et al.
Pageof 3